Overview

4-aminopyridine for Skin Wound Healing

Status:
RECRUITING
Trial end date:
2028-03-01
Target enrollment:
Participant gender:
Summary
Many patients suffer from chronic non-healing wounds as well as acute wounds. There is a need to develop treatments to accelerate and improve healing of chronic and acute wounds. More research is needed to evaluate the role of 4-aminopyridine (4-AP), a promising new agent with an excellent safety profile, on wound healing. The investigational treatment will be used to evaluate the role of (4-AP) on the treatment of wounds to accelerate wound healing in healthy adults. The purpose of this study is to evaluate the role of 4-AP on the treatment of wounds to accelerate healing. The investigational treatment will be used to test the hypothesis that 4-AP can speed wound healing.
Phase:
PHASE2
Details
Lead Sponsor:
John Elfar
Treatments:
4-Aminopyridine